Our US-Based Support team is available to help. Contact Us Now
Phone: 800-441-1045 | Email: support@kidneyhood.org
Kidneyhood is the world's first clinically proven, integrated kidney disease management program. We exist for one reason: to give every CKD patient access to the education, nutrition, and clinical evidence they need to actively manage their disease progression — regardless of where they live or what resources they have.
Why Kidneyhood Exists
CKD progression is largely driven by metabolic, dietary, and lifestyle factors. The world's leading nephrology organizations — KDIGO and KDOQI — both recognize this and recommend very low protein diets supplemented with keto acid analogs as the evidence-based dietary intervention for CKD patients at risk of progression.
In practice, most CKD patients never receive this guidance. Nephrology as a specialty manages CKD primarily through pharmacological intervention and is not structured to provide dietary management. In practice, most nephrologists are not yet aware that KDIGO 2024 and KDOQI 2020 changed their dietary recommendations to support this approach — dietary guideline updates travel differently through the medical system than drug trial results.
The result is a documented gap: more than 30 kidney diet books are published every year, and hundreds have been published over the past two decades. Of all of them, only two have any real clinical data — and only one, the Stopping Kidney Disease series, has been proven in human clinical studies. No integrated dietary program existed that patients worldwide could actually access and follow safely.
Kidneyhood was built specifically to fill that gap.
The Program
The Kidneyhood program combines three components in an integrated system:
- The Kidneyhood very low protein diet — reducing protein to 0.3-0.4 g/kg/day, the target range both KDIGO and KDOQI recommend
- Albutrix keto acid analog — the only keto acid analog clinically proven to improve eGFR and achieve therapeutic BUN levels, with the lowest nitrogen content of any product in its category
- Microtrix multivitamin — the only low-dose multivitamin formulated specifically for kidney patients on a low protein diet
Together, these three components are the only integrated program in the world that guarantees 100% of recommended daily allowances for essential amino acids, vitamins, and minerals while following the VLPD + keto acid analog approach both guidelines recommend.
Clinical Evidence
The Kidneyhood program has been studied in human patients using the same clinical endpoints the FDA uses for kidney disease drug evaluation — eGFR, BUN, and creatinine. Results from the documented pilot study:
- 80% of patients improved eGFR | 92% reduced BUN | 86% lowered creatinine | 25% average eGFR improvement from baseline at six months
- Statistically significant dose-response relationship between achieved BUN level and eGFR improvement (p = 0.002)
- 4,910+ patients across 20+ countries | 8 years of operation | Zero reported adverse events
Guideline Alignment
KDIGO 2024 Practice Point 3.3.1.2 recommends: 'a very low-protein diet (0.3-0.4 g/kg body weight/d) supplemented with essential amino acids or ketoacid analogs.' KDOQI 2020 gives this a Grade 1A rating — the highest evidence classification in guideline medicine. The Kidneyhood program was designed to fulfill this recommendation completely.
Kidneyhood.org Founder — Lee Hull
Kidneyhood.org was founded by Lee Hull, a longtime advocate for education, clarity, and empowerment in the CKD community. After navigating kidney failure himself, Lee became dedicated to helping others avoid the confusion and uncertainty he experienced.
His work has helped thousands better understand kidney nutrition, lifestyle choices, and how to take a more informed role in their kidney-health journey.
You can read more about Lee's story here: About Lee Hull
Albutrix — FDA-Registered Medical Food
Albutrix is an FDA-registered medical food under the Orphan Drug Act (21 U.S.C. 360ee(b)(3)). Medical foods are a distinct regulatory category from drugs — they are not subject to drug approval. Albutrix is manufactured in FDA-registered, lot-tested US facilities and is additionally pursuing FDA 505(b)(2) drug approval.
Available Worldwide
Albutrix ships free to patients in 20+ countries without a prescription. This is a founding principle of Kidneyhood: our founder was personally denied treatment options based on where he lived as a CKD patient. No patient should receive inferior care because of geography or net worth.
Stopping Kidney Disease book series
The Stopping Kidney Disease book series emphasizes education, evidence-based science, and early intervention for CKD patients in stages 3, 4, and 5.
The Stopping Kidney Disease book series includes:
The Kidneyhood Promise to Fellow Patients
We will always keep the Stopping Kidney book series, Albutrix and Microtrix up to date with the most current recommendations. If you are using Kidneyhood.org books and products you are always getting the most up-to-date information and FDA-registered, patented products.
You will never have to wonder if you are doing the right thing again or following the most up-to-date science. You will also be ensured of receiving 100% of the recommended daily amounts (RDA) for essential amino acids, vitamins and minerals. No other program in the world can make this promise.
We are dedicated to helping fellow kidney patients learn how to successfully manage kidney disease so they can live longer, more normal lives by learning how to manage their disease.
US-BASED SUPPORT
Still Have Questions?
FDA-REGISTERED & USA MADE